• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Hologic launches strategic restructuring

Article

In an effort to boost profitability and revenue, Hologic is implementing an expansive restructuring plan aimed at strengthening its competitive position in the women’s health and digital imaging markets. The plan includes a company-wide cost

In an effort to boost profitability and revenue, Hologic is implementing an expansive restructuring plan aimed at strengthening its competitive position in the women’s health and digital imaging markets. The plan includes a company-wide cost savings initiative, expected to bring real annual cost savings of around $10 million by cutting 10% of the workforce and reducing operating expenses. The company expects a restructuring charge, primarily related to severance costs, of about $1.3 million, or 8¢ per diluted share, in the fourth quarter of fiscal 2001, which ends Sept. 29.

The next step in the plan will be to focus on long-term revenue growth through new marketing programs, expanded distribution channels, and development of strategic business relationships. Jack Cumming, Hologic’s new president and CEO, cited costs associated with the acquisitions of Trex Medical in 2000 and Direct Radiography in 1999 and the ongoing investment in digital radiography and digital mammography systems as drags on profitability. Cumming took the helm of Hologics in late July following the death of David Ellenbogen. Cumming had joined Hologic in August 2000 as senior vice president and president of Lorad, a Hologic company.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.